Patent
Prophylactic uses of fully reduced forms of hmgb1 prior to injury
- Publication status:
- Published
Actions
Access Document
- Files:
-
-
(Version of record, 6.3MB)
-
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Bibliographic Details
- Article number:
- WO2019197898A1
- Publication date:
- 2019-04-09
- Patent status:
- Issued/granted
- Territory:
- USA
- Patent number:
-
WO2019197898A1
Item Description
- Language:
- English
- Keywords:
- Documentation:
- The subject invention provides a method of preventing a consequence of an anticipated injury in a subject which comprises administering to the subject a therapeutically effective amount of the fully reduced (all thiol) form of HMGB1 or a biologically active truncated form of HMGB1, so as to prevent the consequence of the anticipated injury.
- Pubs id:
-
1108404
- Local pid:
- pubs:1108404
- Deposit date:
- 2020-06-02
Terms of use
- Copyright holder:
- © the authors
- Copyright date:
- 2019
If you are the owner of this record, you can report an update to it here: Report update to this record